Chongqing Zhifei Bio Products Total Liabilities

Latest as of June 2026: CN¥12.53 Billion CNY ≈ $1.83 Billion USD

Chongqing Zhifei Bio Products total liabilities. Based on the latest financial reports, Chongqing Zhifei Bio Products (300122) has total liabilities worth CN¥12.53 Billion CNY (≈ $1.83 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Chongqing Zhifei Bio Products to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Chongqing Zhifei Bio Products (2007–2025)

Total liabilities of Chongqing Zhifei Bio Products from 2007 to 2025. This chart illustrates how Chongqing Zhifei Bio Products's total liabilities have evolved over time, based on quarterly financial data. Explore Chongqing Zhifei Bio Products long-term investment intensity to see how much of total assets are deployed in long-term investments.

Chongqing Zhifei Bio Products Competitors by Total Liabilities

The table below lists competitors of Chongqing Zhifei Bio Products ranked by their total liabilities.

Company Country Total Liabilities
Bechtle AG
XETRA:BC8
Germany €2.83 Billion
Clear Secure Inc
NYSE:YOU
USA $1.34 Billion
Beijing Jingneng Power Co Ltd
SHG:600578
China CN¥64.06 Billion
FORM.DE C.Y C.ADR 1/5/EO1
F:FCC0
Germany €11.06 Billion
Charoen Pokphand Foods Public Company Limited
BK:CPF
Thailand ฿618.83 Billion
Compal Electronics Inc
TW:2324
Taiwan NT$368.22 Billion
Golar LNG Limited
NASDAQ:GLNG
USA $3.15 Billion
Cupid Limited
NSE:CUPID
India Rs1.02 Billion

Liability Composition Analysis (2007–2025)

This chart breaks down Chongqing Zhifei Bio Products's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Chongqing Zhifei Bio Products.

Liquidity & Leverage Metrics

Chongqing Zhifei Bio Products Total Liabilities Ratios Explained

Chongqing Zhifei Bio Products total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.98 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.83 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.45 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chongqing Zhifei Bio Products's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chongqing Zhifei Bio Products (2007–2025)

The table below shows the annual total liabilities of Chongqing Zhifei Bio Products from 2007 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥15.61 Billion
≈ $2.28 Billion
-18.16%
2024-12-31 CN¥19.08 Billion
≈ $2.79 Billion
+1.88%
2023-12-31 CN¥18.73 Billion
≈ $2.74 Billion
+36.02%
2022-12-31 CN¥13.77 Billion
≈ $2.01 Billion
+11.12%
2021-12-31 CN¥12.39 Billion
≈ $1.81 Billion
+77.73%
2020-12-31 CN¥6.97 Billion
≈ $1.02 Billion
+34.19%
2019-12-31 CN¥5.20 Billion
≈ $760.20 Million
+97.59%
2018-12-31 CN¥2.63 Billion
≈ $384.75 Million
+125.04%
2017-12-31 CN¥1.17 Billion
≈ $170.97 Million
+520.77%
2016-12-31 CN¥188.21 Million
≈ $27.54 Million
-11.39%
2015-12-31 CN¥212.40 Million
≈ $31.08 Million
-17.26%
2014-12-31 CN¥256.72 Million
≈ $37.57 Million
+29.26%
2013-12-31 CN¥198.61 Million
≈ $29.06 Million
+52.15%
2012-12-31 CN¥130.53 Million
≈ $19.10 Million
-10.73%
2011-12-31 CN¥146.22 Million
≈ $21.40 Million
+116.35%
2010-12-31 CN¥67.59 Million
≈ $9.89 Million
+1.89%
2009-12-31 CN¥66.33 Million
≈ $9.71 Million
-46.09%
2008-12-31 CN¥123.05 Million
≈ $18.01 Million
-14.71%
2007-12-31 CN¥144.27 Million
≈ $21.11 Million
--

About Chongqing Zhifei Bio Products

SHE:300122 China Biotechnology
Market Cap
$4.73 Billion
CN¥32.29 Billion CNY
Market Cap Rank
#3578 Global
#437 in China
Share Price
CN¥13.49
Change (1 day)
+4.74%
52-Week Range
CN¥11.37 - CN¥21.77
All Time High
CN¥11976.62
About

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide… Read more